Monday, September 21

Healthcare

Perspective gets FDA fast track status for radiopharmaceutical VMT01

09/06/20241 Min Read

Fast FDA Perspective radiopharmaceutical status track VMT01

Previous ArticleCigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket

Next Article McKesson slips as Q2 outlook underwhelms